Cumberland Pharmaceuticals, Inc. (CPIX) Misses Q1 EPS by 3c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q1 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $12.87 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance